Long-term efficacy of continuous baricitinib treatment in patients with severe alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2; Supplementary Material

Supplementary Material associated with the manuscript Long-term efficacy of continuous baricitinib treatment in patients with severe alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2 published in JAAD.与发表于《美国皮肤病学会杂志》（Journal of the American Academy of Dermatology，JAAD）的论文《重度斑秃患者持续巴瑞替尼（baricitinib）治疗的长期疗效：来自BRAVE-AA1与BRAVE-AA2研究的3年结果》相关的补充材料